EndoNurse Magazine

Colon Cancer (Colorectal Cancer)

Colorectal cancer is the third most-common cancer and the second leading cause of cancer death in men and women in the United States, according to the Colon Cancer Alliance. Colon cancer is cancer of the large intestine, whereas rectal cancer is cancer of the last several inches of the colon. Together, they're referred to as colorectal cancers and often start as benign polyps that could be removed easily through colonoscopy.

EBT Virtual Colonography Marks Colon Cancer Awareness Month at LIFETEST Nashville

NASHVILLE, Tenn. -- LIFETEST Imaging Center of Nashville is highlighting colon cancer awareness month with the introduction of the electron beam tomography (EBT) virtual colonography for colon cancer screening. LIFETEST is the only imaging center in Tennessee to offer the ...More
March 11, 2004
Posted in News, Disorders, Industry Issues, Procedures
Promising New Trial To Fight Colorectal Cancer

New York University School of Medicine investigators are leading a national study, called TREE-2, which will evaluate the safety and efficacy of three regimens of Eloxatin™ plus fluoropymidine, plus Avastin™ as first-line treatment of patients with advanced colorectal ...More
March 11, 2004
Posted in News, Disorders, Industry Issues, Procedures
Innovative Cancer Prevention Outreach Program Launched In Recognition Of National Colorectal Cancer Awareness Month

ATLANTA -- HealthScreen America™, a health screening medical facility in Buckhead, Georgia, announced the launch of The Prevention Partners Program with public service announcements, a fundraiser and special promotion in recognition of Colorectal Cancer Awareness Month. The ...More
March 10, 2004
Posted in News, Disorders, Industry Issues, Procedures
MRI Useful Tool in Diagnosing Inflammatory Bowel Diseases in Children

Magnetic resonance imaging (MRI), coupled with the use of the contrast dye gadolinium, may help pediatricians better diagnose children with ulcerative colitis and Crohn's disease, according to a study by researchers at the Johns Hopkins Children's Center. Results of the ...More
March 5, 2004
Posted in News, Disorders, Industry Issues, Procedures
New Symbol of Hope for Colon Cancer Cure

WASHINGTON — Just as the red ribbon has come to symbolize AIDS and pink represents breast cancer, the blue star symbol introduced by the National Colorectal Cancer Roundtable (NCCRT) will now signify the fight against colon cancer. The symbol has already been adopted by ...More
March 1, 2004
Posted in News, Disorders, Industry Issues, Procedures
Not All Virtual Colonoscopy Systems are Equal in Colon Cancer Detection, Study Reveals

STONY BROOK, N.Y. -- Demonstrating clearly that not all virtual colonoscopies are equal, astudy published in the December 2003 issue of the American Journal of Roentgenology and The New England Journal of Medicine found the Viatronix V3D-Colon system to be ...More
March 1, 2004
Posted in News, Disorders, Industry Issues, Procedures
FDA Approves First Angiogenesis Inhibitor to Treat Colorectal Cancer

The Food and Drug Admionistration (FDA) has approved Avastin (bevacizumab) as a first-line treatment for patients with metastatic colorectal cancer -- cancer that has spread to other parts of the body. Avastin, a monoclonal antibody, is the first product to be approved ...More
February 27, 2004
Posted in News, Disorders, Industry Issues, Procedures
ERBITUX™ (Cetuximab) Receives FDA Approval to Treat Irinotecan Refractory Or Intolerant Metastatic Colorectal Cancer

NEW YORK, and PRINCETON, N.J. -- ImClone Systems Incorporated and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved ERBITUX™ (Cetuximab) Injection for use in combination with irinotecan in the treatment of patients with ...More
February 24, 2004
Posted in News, Disorders, Industry Issues, Procedures
American Cancer Society Working to Boost Pennsylvania Colorectal Cancer Screening Rates

PHILADELPHIA -- Colorectal cancer (commonly referred to as colon cancer) is the second leading cause of cancer death in Pennsylvania, with more than 3,300 state residents expected to die from the disease this year, according to the American Cancer Society. Yet, it is one of ...More
February 23, 2004
Posted in News, Disorders, Industry Issues, Procedures
X-ACT Study Shows Promising Tolerability Results in Patients Receiving Xeloda For the Adjuvant Treatment of Colon Cancer Compared to Standard Treatment

SAN FRANCISCO -- A safety analysis from a major phase III study involving patients with early stage colon cancer, shows that those receiving oral Xeloda (capecitabine) had promising tolerability results compared to those receiving standard i.v. therapy using 5-FU/LV (Mayo ...More
February 18, 2004
Posted in News, Disorders, Industry Issues, Procedures